Agmatine for the treatment of neurotrauma and neurodegenerative diseases
US5677349A · kind A · utility
23Cited by
1References
2Claims
0Family size
Inventors
Key dates
| Filing date | Dec 7, 1995 |
| Grant date | Oct 14, 1997 |
| Priority date | — |
| Expiry date | Dec 7, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/155
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of agmatine, in the treatment of acute neurotrauma (such as stroke) and degenerative disorders of the central and peripheral nervous system (such as dementia).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.